According to SNS Insider, the global Plasmid Purification Market was valued at USD 1.96 billion in 2024 and is expected to reach USD 4.74 billion by 2032, growing at a CAGR of 11.67% during the ...

Investor event in New York City to provide update on pivotal Phase 3 study of IMNN-001; offering in-person or virtual attendance on November 10, ...

KB407 utilizes a replication-defective HSV-1 vector to deliver full-length CFTR to the airway epithelium. The interim readout ...

Bharat Biotech is venturing into advanced therapies by launching Nucelion Therapeutics, a subsidiary focused on cell and gene therapies. This new enti ...

Bharat Biotech expands into advanced biologics with Nucelion Therapeutics, a new CRDMO for cell and gene therapy ...

The Cambridge Index fell 338.31 points or 1.3% to close at 26,348.5, as five out of the top ten index heavyweights posted weekly losses in their share price. Raspberry PI Holdings, down 1.8%, ...

Bharat Biotech launches Nucelion, the next-gen cell and gene therapy, CRDMO: Our Bureau, Bengaluru Monday, November 3, 2025, 17:30 Hrs [IST] Nucelion Therapeutics, a newly establi ...

Bharat Biotech launches Nucelion Therapeutics, a CRDMO in Hyderabad for advanced cell and gene therapy manufacturing and development.

Bharat Biotech launches Nucelion Therapeutics, a CRDMO focused on advanced cell and gene therapies for global life science innovators.

The Needle-Free Injection System Market represents a groundbreaking advancement in medical technology, offering an innovative ...

Trials-in-progress poster of ongoing pivotal Phase 3 trial of DNA-mediated immunotherapy accepted at both IGCS and ESMO Congress ...